Voyager Therapeutics (VYGR) Receivables - Net (2022 - 2025)
Voyager Therapeutics' Receivables - Net history spans 4 years, with the latest figure at $1.8 million for Q4 2025.
- For Q4 2025, Receivables - Net rose 17.09% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, up 17.09%, while the annual FY2025 figure was $1.8 million, 17.09% up from the prior year.
- Receivables - Net for Q4 2025 was $1.8 million at Voyager Therapeutics, down from $3.2 million in the prior quarter.
- Across five years, Receivables - Net topped out at $80.1 million in Q4 2023 and bottomed at $837000.0 in Q1 2024.
- The 4-year median for Receivables - Net is $1.8 million (2025), against an average of $13.0 million.
- The largest annual shift saw Receivables - Net crashed 98.12% in 2024 before it skyrocketed 93.91% in 2025.
- A 4-year view of Receivables - Net shows it stood at $10.0 million in 2022, then skyrocketed by 701.5% to $80.1 million in 2023, then plummeted by 98.12% to $1.5 million in 2024, then increased by 17.09% to $1.8 million in 2025.
- Per Business Quant, the three most recent readings for VYGR's Receivables - Net are $1.8 million (Q4 2025), $3.2 million (Q3 2025), and $1.7 million (Q2 2025).